Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

No increased skin cancer risk was found in alopecia patients treated with photobiomodulation.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

The CNC® prosthetic system improved body image in breast cancer patients with hair loss from chemotherapy but did not significantly change their psychological wellbeing.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Some breast cancer chemotherapy can cause permanent hair loss.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Combining scalp cooling with a special lotion helps prevent severe hair loss in breast cancer patients undergoing chemotherapy.

Chemotherapy often causes hair loss, so patients should be counseled to reduce anxiety.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Personalized hair care strategies are needed for Black cancer patients to prevent hair loss during chemotherapy.

Scalp cooling reduces hair loss during chemotherapy but doesn't help hair regrow after.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

CDK4/6 inhibitors generally maintain quality of life in metastatic breast cancer patients, except for some side effects like diarrhea and hair loss.

Ayurveda-based care may improve quality of life for breast cancer patients without serious side effects.

Hair loss significantly lowers quality of life for cancer patients.

Many medications can cause hair loss or excessive hair growth, which is usually reversible after stopping the drug.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Ayurveda, using herbs like ginger, garlic, and turmeric, can reduce chemo-radiotherapy side effects in cancer patients.